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145 ANTI-INFLAMMATORY AND CHONDRO-PROTECITVE
EFFECTS of ROSE HIP POWDER AND ITS CONSTITUENT
GALACTOLIPIDS GOPO
J.P. Schwager, N. Richard, S. Wolfram. DSM, Basel, SWITZERLAND
Purpose: Clinical studies have shown that rose hip powder (RHP)
exerts beneﬁcial effects in OA patients. Thus, substances contained in
proprietary RHP should have an effect on parameters involved in disease
initiation and progression. Until now only one of its constituents – GOPO –
was shown to inhibit the migration of polymorphonuclear leukocytes. In
this study various in vitro effects of RHP and GOPO related to inﬂamma-
tory processes, erosion of cartilage tissue and chondro-protection were
evaluated.
Methods: Anti-inﬂammatory effects were measured in LPS-activated
macrophage RAW264.7 cells. Cells were cultured for 4−24 hrs with differ-
ent doses of RHP or GOPO. Gene expression was quantiﬁed by RT-PCR;
production of inﬂammatory mediators like PGE2 was measured by ELISA
and nitric oxide determined by the Griess reaction. Substances were
tested on primary human chondrocytes (without and with concomitant
activation of chondrocytes by Il-1beta) and the expression of anabolic
and catabolic genes was monitored by real-time PCR
Results: Rose hip and GOPO inhibit the production of NO (IC50
816±38mg/L and 37.0±6.0mmol/L, respectively). We observed weaker
effects on PGE2 production (IC50 594±43mg/L and >50mmol/L). Ex-
pression of inﬂammatory genes like iNOS, Il-1alpha, MMP-9 was sig-
niﬁcantly reduced by GOPO, but to a lower degree by RHP. In activated
chondrocytes, GOPO decreased the expression of catabolic genes (e.g.
ADAMTS-4, MMP-1, MMP-13), interleukins or chemokines (IL1-alpha,
Il-8, CC5), whereas the expression of collagen or aggreccan genes
was slightly increased. We observed a GOPO-dependent increased
expression level of SOX-5 or SOX-9. RHP had similar although weaker
effects. On a stoichiometric basis, however, the GOPO contents of RHP
does not fully account for the observed biological effects and thus infers
on the presence of additional anti-inﬂammatory and chondro-protective
substances in RHP.
Conclusions: The demonstrated anti-inﬂammatory effects in vitro are
consistent with OA-reducing properties of RHP. In addition, its chondro-
protective and cartilage-rebuidling activities are at least partially attributed
to GOPO, a constituent galactolipid of RHP.
146 DIFFERENTIAL EFFECTS OF HYALURONAN ON
FIBRONECTIN FRAGMENT ACTIONS BETWEEN NORMAL
AND RHEUMATOID ARTHRITIS CARTILAGES
T. Yasuda. Department of Sports Medicine, Tenri University, Tenri,
JAPAN
Purpose: This study was aimed to compare the inhibitory effects of
hyaluronan (HA) on nitric oxide (NO) production by COOH-terminal
heparin-binding ﬁbronectin fragment (HBFN-f) between normal and
rheumatoid arthritis (RA) cartilages.
Methods: Articular cartilage slices from RA knee joints or normal hip
joints were cultured with HBFN-f with or without pretreatment with 2700
kDa HA. Alternatively, isolated RA chondrocytes in monolayer were incu-
bated with HBFN-f. Secreted NO levels in conditioned media were deter-
mined. Induction of inducible nitric oxide synthase (iNOS) was assessed
with immunoblotting. Immunoﬂuorescence histochemistry was performed
using ﬂuorescein isothiocyanate-conjugated anti-CD44 antibody.
Results: HBFN-f stimulated NO production in a dose-dependent manner
in association with iNOS induction in normal and RA cartilages. While
CD44 expression was up-regulated in RA cartilage, HA signiﬁcantly
blocked HBFN-f-stimulated NO production in RA cartilage. Compared with
normal cartilage, cartilage response to HBFN-f and the blocking effects
of HA on HBFN-f action were stronger in RA cartilage.
Conclusions: The present study clearly demonstrated that RA cartilage
exhibited stronger response to HBFN-f leading to NO induction. HA
binding to the increased CD44 in RA cartilage may effectively protect
RA joint destruction by ﬁbronectin fragments like HBFN-f.
147 EXPRESSION OF NOVEL EXTRACELLULAR SULFATASES
SULF-1 AND SULF-2 IN NORMAL AND OSTEOARTHRITIC
ARTICULAR CARTILAGE
S. Otsuki1, N. Taniguchi1, S. Grogan1, D. D’Lima1, M. Kinoshita2,
M. Lotz1. 1The Scripps Research Institute, La Jolla, CA, USA, 2Osaka
Medical College, Osaka, JAPAN
Purpose: The recently identiﬁed novel extracellular sulfatases (Sulf) can
modulate the activity and signaling of important growth factors in cartilage,
such as BMP, bFGF, Wnt and VEGF. The aim of this study was to
analyze expression patterns of Sulf-1 and Sulf-2 in articular cartilage and
chondrocytes.
Methods: Sulf-1 and Sulf-2 expression in human articular cartilage from
normal donors and patients with osteoarthritis (OA), and in normal and
aged mouse joints were analyzed by real-time PCR, immunohistochem-
istry and western blotting.
Figure 1. Sulf-1 and Sulf-2 mRNA expression in articular cartilage were
signiﬁcantly higher in the OA group (Sulf-1: P = 0.001, Sulf-2: P = 0.019).
Figure 2. The OA middle zone had signiﬁcantly more Sulf-1 positive cells
than the other zones (*: P< 0.01). Sulf-2 expression in normal cartilage
was signiﬁcantly higher than Sulf-1 (P = 0.02).
Results: Sulf-1 and Sulf-2 mRNA expression in older OA donors (n = 8;
49−68 years old; Mankin score: 7−10) was signiﬁcantly higher than in
young donors (n = 8; 19−37 years old; Mankin score: 0−2 points) as
determined by real-time PCR (Figure 1). Immunohistochemistry showed
that young and old normal samples had only a few Sulf positive cells in
the superﬁcial zone and no positive cells in the middle and deep zone.
In general, the expression of Sulf-2 appeared more intense than Sulf-1
in normal cartilage. In OA cartilage, many positive cells were detected,
especially in chondrocyte clusters. The normal areas had only 18.5%
Sulf-1 positive and 31.9% Sulf-2 positive cells in the superﬁcial zone,
which was greater than in normal cartilage. On the other hand, OA
areas had 75.3% Sulf-1 positive and 73.2% Sulf-2 positive cells. Figure 2
shows quantitative analysis of the zonal distribution of Sulf-1 and Sulf-2
expressing cells in eight normal (17−37 years old) and eight OA donors
(43−82 years old). The middle zone in OA cartilage had signiﬁcantly more
positive cells than normal (*P< 0.01). Moreover, the number of Sulf-2
positive cells in superﬁcial and middle zone was greater than Sulf-1
expressing cells (P = 0.02). Western blotting revealed higher levels of
Sulf-1 and Sulf-2 protein in OA cartilage as compared to normal tissue.
Temporomandibular joints (TM) and knee joints from normal C57Bl/6J
mice (n = 14) showed only few cells were positive for Sulf-1 but Sulf-2
positive cells at 6 months of age. There was a marked increase in Sulf-2
expression at 9 months and in Sulf-1 expression at 12 months, associated
with the presence of early OA-like lesions.
